Julie Rehmeyer's 'Through the Shadowlands'
Writer Never Give Up talks about Julie Rehmeyer's new book "Through the Shadowlands: A Science Writer's Odyssey into an Illness Science Doesn't Understand" and shares an interview with Julie ...
Discuss the article on the Forums.

New compound triggers immune response to range of RNA viruses, including Ebola and hep C

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by RYO, Dec 22, 2015.

  1. RYO

    RYO Senior Member

    Messages:
    280
    Likes:
    656
    USA
    http://hsnewsbeat.uw.edu/sites/default/files/sites/default/files/documents/J. Virol.-2015.pdf

    "
    Though important advances have been made in treating RNA virus infections such as hepatitis C and influenza, a broad spectrum antiviral drug that throws a blanket over all of them, including more deadly variants like Ebola, has remained out of reach. Scientists are now reporting the discovery of a drug-like molecule that could be used to combat all RNA viruses, by triggering an innate immune response that suppresses and controls the infections.

    As a virus spreads through the body, it takes over individual cellular machinery and uses it to make copies of itself, infecting other cells in the process. While the body can fight off some viruses on its own, others are able to mutate to elude these natural defence mechanisms and go on replicating. Drugs have been developed to treat specific viruses, such as hepatitis C, but they are expensive and some hold concerns that their ongoing use may give rise to drug resistance.

    So a team led by scientists from the University of Washington set out to better equip the body's immune system to fight off viral RNA. It has developed a compound that targets a molecule contained in the body's cells called RIG-1. This molecule is a pathogen recognition receptor, which means that it detects the presence of viral RNA and sets off an innate immune response inside the cell.

    This includes the expression of antiviral genes, pro-inflammatory cytokines, chemokines and interferons, which work in collaboration to suppress and control the viral infection. By activating this immune response and promoting these weapons against infection, the team was able to "significantly decrease" viral RNA in cells and suppress infectious virus reproduction.

    "Our compound has an antiviral effect against all these viruses," says Michael Gale Jr., University of Washington professor of immunology, referring to a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza A, respiratory syncytial, Nipah, Lassa and Ebola.

    The researchers say they have successfully tested the approach in cells and mice, and they are now turning their attention to exploring dosage and stability in animal models. Human trials could follow thereafter, with a timeline of somewhere between two and five years."

    Sounds interesting. It should work on enteroviruses...

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060663/pdf/nihms266914.pdf
     
    Last edited: Dec 22, 2015
    Johannawj, maryb, halcyon and 3 others like this.
  2. Never Give Up

    Never Give Up Collecting improvements, until there's a cure.

    Messages:
    970
    Likes:
    4,015
    Hope it works- without inducing autoimmune disease.
     
    Lyratic, halcyon and maryb like this.
  3. Hip

    Hip Senior Member

    Messages:
    10,750
    Likes:
    17,815
    The antiviral compound in that study is KIN1400 (plus similar compounds like KIN1409). However, there is very little info about KIN1400 that I could find online.

    The study authors refer to one of their earlier studies in which they identified a class of isoflavone antiviral compounds that also work on IRF-3. In particular, one of these KIN101, also as a broad-spectrum activity against RNA viruses.
     
    Last edited: Dec 26, 2015
    halcyon and maryb like this.
  4. halcyon

    halcyon Senior Member

    Messages:
    2,352
    Likes:
    5,518
    I wonder if these KIN compounds are modified or isolated in a specific way, or if you'd be able to obtain any amount of them by taking something like genistein.
     
  5. Hip

    Hip Senior Member

    Messages:
    10,750
    Likes:
    17,815
    The study talks about using high-throughput screening to identify small molecules to stimulate RIG-I immune signaling. Not sure how high-throughput screening of molecules works.
     

See more popular forum discussions.

Share This Page